Coherus Biosciences Stock Price History
| CHRS Stock | USD 1.18 0.17 12.59% |
Below is the normalized historical share price chart for Coherus BioSciences extending back to November 06, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Coherus BioSciences stands at 1.18, as last reported on the 1st of February, with the highest price reaching 1.18 and the lowest price hitting 1.18 during the day.
If you're considering investing in Coherus Stock, it is important to understand the factors that can impact its price. Coherus BioSciences is dangerous given 3 months investment horizon. Coherus BioSciences secures Sharpe Ratio (or Efficiency) of 0.15, which signifies that the company had a 0.15 % return per unit of risk over the last 3 months. We were able to interpolate data for twenty-seven different technical indicators, which can help you to evaluate if expected returns of 1.26% are justified by taking the suggested risk. Use Coherus BioSciences Risk Adjusted Performance of 0.1253, mean deviation of 5.49, and Downside Deviation of 5.1 to evaluate company specific risk that cannot be diversified away.
At this time, Coherus BioSciences' Other Stockholder Equity is comparatively stable compared to the past year. Common Stock is likely to gain to about 13.3 K in 2025, whereas Common Stock Shares Outstanding is likely to drop slightly above 54.8 M in 2025. . Price Earnings To Growth Ratio is likely to gain to 0.04 in 2025, whereas Price To Sales Ratio is likely to drop 1.33 in 2025. Coherus Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 6th of November 2014 | 200 Day MA 1.4483 | 50 Day MA 1.3848 | Beta 0.693 |
Coherus |
Sharpe Ratio = 0.1522
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CHRS | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 8.25 actual daily | 73 73% of assets are less volatile |
Expected Return
| 1.26 actual daily | 25 75% of assets have higher returns |
Risk-Adjusted Return
| 0.15 actual daily | 11 89% of assets perform better |
Based on monthly moving average Coherus BioSciences is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Coherus BioSciences by adding it to a well-diversified portfolio.
Price Book 73.1897 | Enterprise Value Ebitda 8.8137 | Price Sales 0.5141 | Shares Float 103.3 M | Wall Street Target Price 5.9 |
Coherus BioSciences Stock Price History Chart
There are several ways to analyze Coherus Stock price data. The simplest method is using a basic Coherus candlestick price chart, which shows Coherus BioSciences price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | December 3, 2024 | 1.71 |
| Lowest Price | November 4, 2024 | 0.67 |
Coherus BioSciences February 1, 2025 Stock Price Synopsis
Various analyses of Coherus BioSciences' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Coherus Stock. It can be used to describe the percentage change in the price of Coherus BioSciences from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Coherus Stock.| Coherus BioSciences Price Action Indicator | (0.09) | |
| Coherus BioSciences Price Rate Of Daily Change | 0.87 |
Coherus BioSciences February 1, 2025 Stock Price Analysis
Coherus Stock Price History Data
The price series of Coherus BioSciences for the period between Sun, Nov 3, 2024 and Sat, Feb 1, 2025 has a statistical range of 1.04 with a coefficient of variation of 27.69. The prices are distributed with arithmetic mean of 1.24. The median price for the last 90 days is 1.35. The company had 2:1 stock split on December 8, 1992. Coherus BioSciences issued dividends on Jun 26, 1995.| Open | High | Low | Close | Volume | ||
02/01/2025 | 1.35 | 1.18 | 1.18 | 1.18 | ||
02/01/2025 | 1.35 | 1.39 | 1.18 | 1.18 | ||
| 01/30/2025 | 1.23 | 1.39 | 1.23 | 1.35 | 2,894,148 | |
| 01/29/2025 | 1.12 | 1.25 | 1.10 | 1.22 | 3,218,212 | |
| 01/28/2025 | 1.15 | 1.19 | 1.03 | 1.11 | 4,908,009 | |
| 01/27/2025 | 1.19 | 1.29 | 1.13 | 1.16 | 4,032,087 | |
| 01/24/2025 | 1.34 | 1.38 | 1.21 | 1.24 | 3,215,018 | |
| 01/23/2025 | 1.33 | 1.36 | 1.24 | 1.28 | 4,266,147 | |
| 01/22/2025 | 1.35 | 1.45 | 1.29 | 1.31 | 2,890,653 | |
| 01/21/2025 | 1.41 | 1.43 | 1.31 | 1.32 | 2,121,180 | |
| 01/17/2025 | 1.41 | 1.46 | 1.39 | 1.39 | 858,233 | |
| 01/16/2025 | 1.48 | 1.48 | 1.38 | 1.42 | 1,441,853 | |
| 01/15/2025 | 1.50 | 1.55 | 1.44 | 1.46 | 1,344,190 | |
| 01/14/2025 | 1.47 | 1.60 | 1.44 | 1.44 | 2,352,533 | |
| 01/13/2025 | 1.46 | 1.50 | 1.44 | 1.47 | 1,203,293 | |
| 01/10/2025 | 1.50 | 1.51 | 1.44 | 1.47 | 1,401,293 | |
| 01/08/2025 | 1.58 | 1.65 | 1.50 | 1.51 | 1,185,593 | |
| 01/07/2025 | 1.63 | 1.66 | 1.56 | 1.57 | 1,328,381 | |
| 01/06/2025 | 1.65 | 1.77 | 1.61 | 1.62 | 2,946,691 | |
| 01/03/2025 | 1.40 | 1.67 | 1.39 | 1.66 | 3,318,622 | |
| 01/02/2025 | 1.43 | 1.46 | 1.35 | 1.40 | 1,707,729 | |
| 12/31/2024 | 1.48 | 1.52 | 1.37 | 1.38 | 2,168,015 | |
| 12/30/2024 | 1.49 | 1.53 | 1.43 | 1.50 | 1,923,231 | |
| 12/27/2024 | 1.46 | 1.58 | 1.44 | 1.49 | 1,905,460 | |
| 12/26/2024 | 1.47 | 1.49 | 1.41 | 1.49 | 1,266,648 | |
| 12/24/2024 | 1.45 | 1.48 | 1.35 | 1.47 | 1,052,866 | |
| 12/23/2024 | 1.51 | 1.52 | 1.37 | 1.43 | 3,015,835 | |
| 12/20/2024 | 1.44 | 1.54 | 1.40 | 1.52 | 4,297,724 | |
| 12/19/2024 | 1.60 | 1.60 | 1.45 | 1.48 | 2,745,579 | |
| 12/18/2024 | 1.75 | 1.75 | 1.54 | 1.57 | 3,159,020 | |
| 12/17/2024 | 1.66 | 1.75 | 1.57 | 1.71 | 2,720,317 | |
| 12/16/2024 | 1.60 | 1.73 | 1.55 | 1.70 | 3,196,169 | |
| 12/13/2024 | 1.50 | 1.65 | 1.50 | 1.61 | 2,546,102 | |
| 12/12/2024 | 1.64 | 1.67 | 1.50 | 1.50 | 3,837,210 | |
| 12/11/2024 | 1.60 | 1.67 | 1.53 | 1.65 | 2,880,899 | |
| 12/10/2024 | 1.70 | 1.72 | 1.60 | 1.61 | 3,297,205 | |
| 12/09/2024 | 1.78 | 1.85 | 1.67 | 1.70 | 5,702,936 | |
| 12/06/2024 | 1.49 | 1.74 | 1.45 | 1.70 | 5,016,172 | |
| 12/05/2024 | 1.80 | 1.80 | 1.50 | 1.51 | 7,706,092 | |
| 12/04/2024 | 1.82 | 1.95 | 1.68 | 1.71 | 13,164,770 | |
| 12/03/2024 | 2.04 | 2.43 | 1.67 | 1.71 | 114,890,676 | |
| 12/02/2024 | 1.25 | 1.38 | 1.22 | 1.37 | 4,337,392 | |
| 11/29/2024 | 1.28 | 1.31 | 1.21 | 1.22 | 1,866,747 | |
| 11/27/2024 | 1.30 | 1.35 | 1.23 | 1.26 | 3,272,294 | |
| 11/26/2024 | 1.22 | 1.39 | 1.19 | 1.28 | 6,096,149 | |
| 11/25/2024 | 1.12 | 1.34 | 1.12 | 1.21 | 7,479,823 | |
| 11/22/2024 | 1.09 | 1.15 | 1.05 | 1.09 | 2,741,570 | |
| 11/21/2024 | 1.07 | 1.17 | 1.01 | 1.10 | 5,076,616 | |
| 11/20/2024 | 0.82 | 1.13 | 0.81 | 1.10 | 8,858,363 | |
| 11/19/2024 | 0.78 | 0.83 | 0.75 | 0.82 | 2,136,064 | |
| 11/18/2024 | 0.74 | 0.80 | 0.74 | 0.78 | 2,708,183 | |
| 11/15/2024 | 0.80 | 0.80 | 0.70 | 0.74 | 3,005,811 | |
| 11/14/2024 | 0.80 | 0.83 | 0.77 | 0.77 | 2,450,145 | |
| 11/13/2024 | 0.85 | 0.88 | 0.77 | 0.78 | 2,372,039 | |
| 11/12/2024 | 0.78 | 0.89 | 0.77 | 0.82 | 3,564,259 | |
| 11/11/2024 | 0.82 | 0.85 | 0.78 | 0.78 | 2,566,670 | |
| 11/08/2024 | 0.83 | 0.86 | 0.77 | 0.82 | 3,525,228 | |
| 11/07/2024 | 0.80 | 0.96 | 0.76 | 0.82 | 9,457,985 | |
| 11/06/2024 | 0.75 | 0.76 | 0.70 | 0.72 | 4,480,226 | |
| 11/05/2024 | 0.66 | 0.73 | 0.66 | 0.73 | 1,911,113 | |
| 11/04/2024 | 0.72 | 0.75 | 0.67 | 0.67 | 3,112,174 |
About Coherus BioSciences Stock history
Coherus BioSciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Coherus is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Coherus BioSciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Coherus BioSciences stock prices may prove useful in developing a viable investing in Coherus BioSciences
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 108.3 M | 54.8 M | |
| Net Loss | -262.6 M | -249.4 M |
Coherus BioSciences Quarterly Net Working Capital |
|
Coherus BioSciences Stock Technical Analysis
Coherus BioSciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Commodity Channel Now
Commodity ChannelUse Commodity Channel Index to analyze current equity momentum |
| All Next | Launch Module |
Coherus BioSciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Coherus BioSciences' price direction in advance. Along with the technical and fundamental analysis of Coherus Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Coherus to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1253 | |||
| Jensen Alpha | 0.9338 | |||
| Total Risk Alpha | 0.2383 | |||
| Sortino Ratio | 0.1949 | |||
| Treynor Ratio | 0.6507 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Coherus Stock Analysis
When running Coherus BioSciences' price analysis, check to measure Coherus BioSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coherus BioSciences is operating at the current time. Most of Coherus BioSciences' value examination focuses on studying past and present price action to predict the probability of Coherus BioSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coherus BioSciences' price. Additionally, you may evaluate how the addition of Coherus BioSciences to your portfolios can decrease your overall portfolio volatility.